23 July 1999
Operating from 76 different countries, the company’s extensive drug portfolio includes the ulcer blockbuster Zantac and the asthma inhaler Ventolin. Glaxo Wellcome is about to launch two new products: Ziagen, a new anti-HIV treatment, and its latest asthma drug, Flixotide.
You must be logged in to continue
Register for free to finish this article.
Sign up now for the following benefits:
To access this article REGISTER NOW
Would you like print copies, app and digital replica access too? SUBSCRIBE for as little as £5 per week.